In a retrospective population-based study, Fan et al. found that treatment of T2DM patients with GLP-1 RA was associated with a significantly lower incidence of superficial keratitis and dry eye disease, which was more pronounced in patients younger than 60 years old. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.